Metformin inhibits OCT3-mediated serotonin transport in the placenta
Jazyk angličtina Země Francie Médium print-electronic
Typ dokumentu časopisecké články
PubMed
39243433
DOI
10.1016/j.biopha.2024.117399
PII: S0753-3322(24)01284-8
Knihovny.cz E-zdroje
- Klíčová slova
- OCT3, gestational diabetes mellitus, metformin, placenta, pregnancy, serotonin,
- MeSH
- biologický transport účinky léků MeSH
- hypoglykemika farmakologie MeSH
- krysa rodu Rattus MeSH
- kultivované buňky MeSH
- lidé MeSH
- metformin * farmakologie MeSH
- oktamerní transkripční faktor 3 metabolismus MeSH
- placenta * metabolismus účinky léků MeSH
- potkani Wistar MeSH
- proteiny přenášející organické kationty MeSH
- serotonin * metabolismus MeSH
- těhotenství MeSH
- trofoblasty * metabolismus účinky léků MeSH
- zvířata MeSH
- Check Tag
- krysa rodu Rattus MeSH
- lidé MeSH
- těhotenství MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- hypoglykemika MeSH
- metformin * MeSH
- oktamerní transkripční faktor 3 MeSH
- proteiny přenášející organické kationty MeSH
- serotonin * MeSH
- solute carrier family 22 (organic cation transporter), member 3 MeSH Prohlížeč
Proper fetal development requires tight regulation of serotonin concentrations within the fetoplacental unit. This homeostasis is partly maintained by the placental transporter OCT3/SLC22A3, which takes up serotonin from the fetal circulation. Metformin, an antidiabetic drug commonly used to treat gestational diabetes mellitus, was shown to inhibit OCT3. We, therefore, hypothesized that its use during pregnancy could disrupt placental serotonin homeostasis. This hypothesis was tested using three experimental model systems: primary trophoblast cells isolated from the human term placenta, fresh villous human term placenta fragments, and rat term placenta perfusions. Inhibition of serotonin transport by metformin at three concentrations (1 μM, 10 μM, and 100 μM) was assessed in all three models. The OCT3 inhibitor decynium-22 (100 μM) and paroxetine (100 μM), a dual inhibitor of SERT and OCT3, were used as controls. In primary trophoblasts, paroxetine exhibited the strongest inhibition of serotonin uptake, followed by decynium-22. Metformin showed a concentration-dependent effect, reducing serotonin uptake by up to 57 % at the highest concentration. Its inhibitory effect was less pronounced in fresh villous fragments but remained statistically significant at all concentrations. In the perfused rat placenta, metformin demonstrated a concentration-dependent effect, reducing placental serotonin uptake by 44 % at the highest concentration tested. Our findings across all experimental models show inhibition of placental OCT3 by metformin, resulting in reduced serotonin uptake by the trophoblast. This sheds light on mechanisms that may underpin metformin-mediated effects on fetal development.
Citace poskytuje Crossref.org